Hester Biosciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hester Biosciences has filed a regulatory disclosure with the stock exchanges confirming that the Promoters and Promoter Group, along with persons acting in concert, have not created any encumbrance (pledge, lien, or charge) on their shareholdings during the financial year ended 31 March 2025. The declaration was submitted by Mr. Rajiv Gandhi on behalf of the promoter group, as required under SEBI's takeover regulations. The filing has also been requested to be placed before the company's Audit Committee for noting. This is a routine annual compliance requirement applicable to promoter entities.
This is a neutral-to-mildly positive filing. It confirms that the promoters have not pledged any of their shares, which is generally seen as a sign of financial stability and confidence in the company. No material change in shareholding or governance is implied.